Heze Technology has secured 30 million yuan in angel financing from Kunlun Capital to advance its innovative flexible brain-computer interface technology.

Target Company Overview

Heze Technology (Symbionics), a startup focused on brain-computer interface (BCI) technology, has successfully raised 30 million yuan in its angel round of financing, fully funded by Kunlun Capital. Established in 2023, Heze Technology is at the forefront of developing flexible brain-computer interface devices. This marks a significant advancement in BCI technology, commemorating the 50th anniversary since the original concept of BCIs was introduced in 1973. Historically, progress in BCI technology was hampered by technical limitations; however, advancements in material science and nanotechnology have led to the development of next-generation BCIs capable of facilitating direct communication between carbon-based life forms and silicon-based devices, expanding the boundaries of human cognitive capabilities.

BCI technology exhibits vast applications across various fields, including healthcare, rehabilitation, and entertainment. In the medical field, BCIs can be applied in neural prosthetics and neuro-regulation, assisting individuals with disabilities and neurological disorders to regain normalcy in their lives. In entertainment, BCIs can enhance virtual reality and metaverse experiences, providing consumers with immersive interactions. Furthermore, the potential applications of BCIs extend to military, education, industrial, and security sectors. BCIs can be categorized into non-invasive and invasive types, with non-invasive systems showing early developments but facing limitations due to natural anatomical barriers, leading to signal resolution constraints. Conversely, invasive BCIs, which originated from clinical practices utilizing hard Utah electrodes in the 1990s, have demonstrated various capabilities while also revealing issues such as immune rejection and signal drift, presenting challenges in addressing market demands.

Industry Overview of Brain-Computer Interfaces in China

China has been increasingly proactive in developing brain-computer interface technologies, receiving substantial government support, illustrated by the launch of the 'China Brain Project' in September 2021. This initiative encompasses 59 research areas, including the study of flexible BCIs, showcasing the country's commitm

View Source

Similar Deals

启明创投 蔚程医药有限公司

2025

Seed Stage Advanced Medical Equipment & Technology (NEC) China
启明创投 微滔生物科技(上海)有限公司

2025

Seed Stage Proprietary & Advanced Pharmaceuticals China
济峰资本 依利特科技

2024

Seed Stage In-Vivo Diagnostic & Testing Substances China
光点资本 红瑞生物

2023

Seed Stage Biotechnology & Medical Research (NEC) China
Adicon Holdings Limited Crown Bioscience Inc.

2026

Other Biotechnology & Medical Research (NEC) China

昆仑资本

invested in

和泽科技

in 2023

in a Seed Stage deal

Disclosed details

Transaction Size: $4M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert